Tien Lee is the founder of Aardvark Therapeutics. Latest round: Series C. Based in Palo Alto, CA.
Tien Lee (also referred to as Tien-li Lee) is the Founder and CEO of Aardvark Therapeutics, a clinical-stage biopharmaceutical company developing small-molecule therapeutics for metabolic diseases by targeting bitter taste receptors in the gut. He led the company through an oversubscribed Series C round to advance its lead candidate, ARD-101, into Phase 3 trials for Prader-Willi Syndrome and hypothalamic obesity. Lee holds over 2.97 million shares of Aardvark Therapeutics Inc (AARD), valued at approximately $30 million as of February 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library